Reena L Pande
Overview
Explore the profile of Reena L Pande including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pande R, Creager M
Circ Cardiovasc Qual Outcomes
. 2014 Jul;
7(4):532-9.
PMID: 24987053
Background: Lower socioeconomic status is associated with cardiovascular disease. We sought to determine whether there is a higher prevalence of peripheral artery disease (PAD) in individuals with lower socioeconomic status....
12.
Aboyans V, Criqui M, Abraham P, Allison M, Creager M, Diehm C, et al.
Circulation
. 2012 Nov;
126(24):2890-909.
PMID: 23159553
No abstract available.
13.
14.
Pande R
Curr Treat Options Cardiovasc Med
. 2012 Jan;
14(2):177-83.
PMID: 22270374
Hyperlipidemia increases the incidence of atherosclerotic vascular disease and is associated with greater rates of recurrent cardiovascular events among individuals with established vascular disease. Several large population studies have confirmed...
15.
Lee M, Pande R, Rao B, Landzberg M, Kwong R
Circulation
. 2011 Nov;
124(21):2362-4.
PMID: 22105199
No abstract available.
16.
Wara A, Foo S, Croce K, Sun X, Icli B, Tesmenitsky Y, et al.
Blood
. 2011 Aug;
118(24):6450-60.
PMID: 21828131
Emerging evidence demonstrates that proangiogenic cells (PACs) originate from the BM and are capable of being recruited to sites of ischemic injury where they contribute to neovascularization. We previously determined...
17.
Pande R, Perlstein T, Beckman J, Creager M
Circulation
. 2011 Jun;
124(1):17-23.
PMID: 21690489
Background: Whether individuals with peripheral artery disease (PAD) identified by screening ankle-brachial index benefit from preventive therapies to reduce cardiovascular risk is unknown. We aimed to determine the number of...
18.
Pande R, Park M, Perlstein T, Desai A, Doyle J, Navarrete N, et al.
Arterioscler Thromb Vasc Biol
. 2010 Nov;
31(1):190-6.
PMID: 21051665
Objective: Reduced limb perfusion from arterial stenosis does not adequately account for intermittent claudication symptoms in peripheral artery disease (PAD). Insulin resistance is associated with PAD and may contribute to...
19.
Pande R, Hiatt W, Zhang P, Hittel N, Creager M
Vasc Med
. 2010 Apr;
15(3):181-8.
PMID: 20385711
Pharmacologic therapy for intermittent claudication in patients with peripheral artery disease (PAD) is limited. We aimed to determine the durability of cilostazol treatment response over time, treatment effects in various...
20.
Perlstein T, Pande R, Creager M, Weuve J, Beckman J
Am J Med
. 2008 Aug;
121(9):781-788.e1.
PMID: 18724968
Background: Bilirubin inhibits experimental atherosclerosis, is inversely associated with carotid plaque burden, and confers neuroprotection in experimental stroke. Clinical data addressing the association of bilirubin with stroke are not available....